Yoram Azulai
Chief Executive Officer bei HBL - HADASIT BIO-HOLDINGS LTD
Profil
Yoram Azulai is currently the Chief Executive Officer, CFO & Secretary at HBL- Hadasit Bio-Holdings Ltd.
He is also a Director at Zingenix Ltd.
and Tolaren Ltd.
Previously, he served as a Director at ProtAb Ltd.
Aktive Positionen von Yoram Azulai
Unternehmen | Position | Beginn |
---|---|---|
HBL - HADASIT BIO-HOLDINGS LTD | Chief Executive Officer | 31.03.2020 |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Director/Board Member | - |
Tolaren Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von Yoram Azulai
Unternehmen | Position | Ende |
---|---|---|
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HBL - HADASIT BIO-HOLDINGS LTD | Finance |
Private Unternehmen | 3 |
---|---|
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Health Technology |
Tolaren Ltd. |